Authors' objectives: Recent advances in technology have permitted the first attempts at sight restoration by combining a patient's native intrinsic visual pathway with advanced light sensing, signal processing, and stimulation components in the form of an ocular prosthesis. Because of the novelty that this technology represents and the recent approval by the U.S. Food and Drug Administration (FDA) for use of one system in patients with retinitis pigmentosa (RP), the Agency for Healthcare Research and Quality (AHRQ) commissioned the ECRI Institute–Penn Medicine Evidence-based Practice Center to prepare this Technology Assessment to provide an overview of retinal prosthesis systems (RPSs). This assessment will summarize the current state of RPSs as well as the existing evidence addressing their clinical utility and the potential future directions for research in areas in which information is limited.

Project Status: Completed

URL for project: http://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/rentinal-prosthesis-protocol.pdf

Year Published: 2016

URL for published report: https://www.ncbi.nlm.nih.gov/books/NBK401297

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: United States

Organisation Name: Agency for Healthcare Research and Quality

Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;

Contact Name: martin.erlichman@ahrq.hhs.gov

Contact Email: martin.erlichman@ahrq.hhs.gov

Copyright: Agency for Healthcare Research and Quality (AHRQ)